daunorubicin has been researched along with alitretinoin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bengtzen, S; Broberg, U; Lehmann, S; Paul, C | 1 |
2 other study(ies) available for daunorubicin and alitretinoin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of retinoids on cell toxicity and apoptosis in leukemic blast cells from patients with non-M3 AML.
Topics: Acute Disease; Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Alitretinoin; Antibiotics, Antineoplastic; Antigens, CD34; Antineoplastic Agents; Apoptosis; Daunorubicin; Drug Synergism; Female; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Male; Middle Aged; Neoplastic Stem Cells; Tretinoin; Tumor Cells, Cultured | 2000 |